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Cell and gene therapy may alter the outcome of renal
diseases, such as hereditary nephropathies, acute and
chronic glomerulonephritis and allograft nephropathy.
However, owing to blockade of many viral and cellular
vehicles by the complex glomerular architecture, the exact
nature of gene and cell delivery into specific renal
compartments remains currently unknown. To study the
interaction of viral vectors with a variety of renal cells and
mesenchymal stem cells (MSCs), we employed a novel
biological three-dimensional (3D) matrix comprised of fibrin
microbeads (FMB) in comparison to monolayer cell culture.
Our studies showed that renal cells of both established and
primary lines can grow efficiently on FMB and differentiate
into epithelial structures, as shown by electron microscopy.
Gene delivery into renal cells in 3D was observed for several
viral vectors and growth in 3D on FMB conferred resistance
to renal cancer cells in the context of oncolytic adenoviruses.
Finally, MSCs from various rodent species attached to FMB,
grew robustly, survived for several weeks and could
efficiently be transduced on FMB. Thus, on the basis of
growth, differentiation and transduction of renal cells in 3D,
FMB emerge as a novel 3D cellular microenvironment that
differs substantially from monolayer cell cultures.
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Cell and gene therapy may alter the natural progression of a
number of renal diseases, such as hereditary nephropathies,
glomerulonephritis, allograft nephropathy and renal cancer.
However, currently available vectors barely target specific
renal compartments,1 probably because of the complex
glomerular architecture blocking particles with a diameter
larger than 100 nm,2–5 and the rapid hepatic clearance of
particles from the circulation.6,7 The kidneys can also be
accessed retrogradely, via the ureter or the renal vein, but
these approaches are unlikely to result in significant targeting
of the critical renal compartment, that is, the cortex.8,9 As the
study of cell and gene delivery in vivo into renal compart-
ments is limited, new methods are required to examine the
interaction of renal tissues with viral and cellular vehicles. In
this regard, the merits of culturing cells in three-dimensional
(3D) cultures have been shown recently.10–15 3D cell culture
differs from standard cell culture in cellular growth and
differentiation patterns, in addition to cellular interaction
with the extracellular matrix.12,16 Whereas the superiority of
3D cell culture has been shown predominantly in the context
of cancer and development, other areas in biological research,
such as basic cell biology, high-content drug screening and
regenerative medicine, are also expected to benefit from 3D
cell culture systems. Based on these considerations, we have
employed fibrin microbeads (FMB) as a 3D cell culture
platform to assess cell and gene therapy strategies in the
context of the kidney. FMB are prepared from human
fibrinogen and thrombin and have a particle diameter range
of 100–300 mm. It has been previously shown that FMB
maintain cell growth for several weeks after which they
degrade.
Cells on FMB can download to seed two-dimensional
(2D) culture flasks without trypsinization. Furthermore, cells
grown on rotating FMB may reach a high density, in the
order of up to 100 million cells per gram of FMB.17–19 In this
study, we evaluated the utility of FMB as a platform for gene
and cell delivery in the context of the kidney. Of note, the
kidney contains a wide spectrum of cellular phenotypes,
demonstrating epithelial (tubular) and mesenchymal (in-
cluding mesangial, myofibroblast, smooth muscle and
endothelial cells) phenotypes. Additionally, renal cells are
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highly differentiated, for example, podocytes, and may also
transdifferentiate, for example, from an epithelial tubular
phenotype into myofibroblasts following profibrotic cues. In
our studies, we observed that a wide variety of renal cells
could be grown and transduced on FMB. Specifically, renal
cells from both glomerular and tubular compartments could
be efficiently grown on FMB, and renal tubular cells
differentiated into epithelial structures on FMB as shown
with electron microscopy. Furthermore, 3D renal cell growth
on FMB clearly differed from standard 2D monolayer
conditions in terms of cell growth and survival. Finally,
FMB could serve both as a platform for growing and
transducing ex vivo mesenchymal stem cells (MSCs), an
emerging renoprotective strategy.20
RESULTS
Renal cell growth and differentiation on FMB
A variety of established renal cell lines were loaded onto FMB
(Figure 1). Renal epithelial cells (human (embryonic kidney
cell line (HEK 293)), porcine proximal tubular cells (LLC-
PK1) and monkey (Vero)) as well as murine podocytes and
mesangial cells, and human renal cancer cells (CaKi-1) could
be grown efficiently on FMB (Figure 1). HEK 293 and Vero
renal epithelial cells proliferated robustly on FMB for more
than 5 weeks and formed multilayered 3D structures, whereas
in 2D they reached confluence and died within 10 days. Of
note, renal cancer cells aggregated on FMB and formed a 3D
cellular niche among the beads. As established cell lines differ
significantly from primary cells, we also studied whether
primary renal cells could grow on FMB (Figure 2). Primary
cells from all rat renal compartments attached and grew on
FMB, including renal cells from the papilla, considered the
site of renal stem cells.21 However, the growth rate of primary
renal cells on FMB was less robust than the growth of
established renal cell lines. To determine whether renal
tubular cells can differentiate on FMB, we used transmission
electron microscopy (TEM) of embedded sections of porcine
renal tubular cells grown on FMB. The TEM images revealed
typical epithelial structures, that is, tight and adherens
junctions and desmosomes between adjacent cells, brush-
border microvilli at apical surfaces, cytoplasmic glycogen and
secretory vacuoles (Figure 3). Thus, when grown on FMB as a
3D culture matrix, renal cells can both grow efficiently and
differentiate.
FMB as a platform for gene delivery into renal cells growing
on a 3D matrix
To study the efficacy of gene delivery into renal cells grown
on FMB, we employed adenoviral (Ad) vectors encoding
reporter genes. Renal epithelial and mesangial cells on FMB
were efficiently transduced with the viral vectors, as evident
by robust reporter gene expression (Figure 4). As endothelial
cells are also a central component of the glomerulus, gene
delivery into bovine aortic endothelial cells growing on FMB
(Figure 4) is also of interest. Thus, a variety of renal cells
growing on FMB can be efficiently transduced by viral
vectors.
Viral-mediated renal cancer cell killing on FMB vs monolayer
To evaluate the kinetics of viral-mediated renal cancer cell
cytolysis (oncolysis) on a 3D matrix, we seeded equivalent
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Figure 1 | Established renal cell lines grow efficiently on FMB. One
or two million cells from a variety of established renal cell lines were
loaded onto FMB and grown in suspension at slow rotation. Left,
phase microsopy images. Right, propidium iodide (PI)-stained nuclei
captured via fluorescence microscopy. (a) Caki-1, human cancer
kidney cells, (b) Vero, monkey renal epithelial cells, (c) HEK 293,
human embryonic renal tubular cells, (d) murine podocytes and
(e) murine mesangial cells,  10.
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Figure 2 | Primary, low-passage renal cells grow on FMB.
(a) Normal rat kidney was dissected into cortex, papilla and outer
medulla. Following digestion with collagenase, suspended cells were
isolated, loaded on FMB and grown in the corresponding medium.
(a–c) PI stain of primary rat renal cells derived from cortex, papilla and
outer medulla, respectively,  10.
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numbers of human renal cancer cells (CaKi-1) on FMB or in
standard monolayer culture plates (Figures 5–7). Cells were
infected with either a replicative, oncolytic Ad or its
replication-incompetent control. In the first experiment,
both Ad vectors encoded the green fluorescent protein (GFP)
reporter gene, either in a replicative Ad (AdD24RGDGFP) or
in a non-replicative Ad (AdRGD-GL) (Table 1). Next, we
followed the renal cancer cells for viral-mediated gene
expression and cell death. When grown in monolayer,
CaKi-1 cells that had been infected at a low multiplicity of
infection (MOI) with the replication-incompetent AdRGD-
GL were hardly transduced. In contrast, at the same MOI, the
replication-competent AdD24RGDGFP induced substantial
GFP expression 3–4 days after the infection, which was
simultaneous in all cancer cells and was followed by 100% cell
killing within 6–7 days (Figures 5 and 7).
However, in Caki-1 cells grown on FMB, infection by
AdD24RGDGFP resulted in time-dependent GFP expression,
manifesting peak reporter gene expression on days 4–8 after
infection and gradually subsiding. On days 11–14 after
infection, gene expression completely disappeared and most
cells, but not all, were killed by the virus (Figure 6, acridine
orange–ethidium orange double stain). Also, the kinetics of
cell death significantly differed on FMB vs monolayer
(Figure 6 vs Figure 5, and Figure 7). Furthermore, unlike
cells in monolayer, dead cells remained adherent to their
matrix (Figure 6, Hoechst stain). Of note, on day 7, lactate
dehydrogenase (LDH) levels in media of cells on FMB were
equivalent whether infected with either the replicative or
non-replicative Ad virus (Figure 7b), and 14 days were
required for the replicative Ad virus to induce doubling of
LDH levels (indirectly reflecting cell death) in cells on FMB
(Figure 7b and e). Thus, whereas in monolayer conditions the
oncolytic AdD24RGDGFP could efficiently eliminate all the
renal cancer cells within 6–7 days (Figures 5 and 7), survival
of Caki-1 cells on FMB was prolonged, thereby better
mimicking in vivo conditions (Figures 6 and 7).
To confirm these findings, we employed another pair of
Ad viruses, the replication-competent AdE1LacZ and its
replication-incompetent control, Adempty, to infect CaKi-1
cells grown as before in monolayer or on FMB. Cell viability
was assessed quantitatively using a 3-(4,5-dimethylthiazol-2-
yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tet-
razolium (MTS) assay (Figure 7c, d and f). Again, while the
*
Figure 3 | Epithelial renal tubular cells differentiate on FMB.
Porcine epithelial renal cells, LLC-PK1, were loaded onto FMB
and allowed to differentiate for a week. Next, cells on FMB were
processed for TEM. The following characteristics of epithelial
differentiation were observed; epithelial cell–cell adherens and tight
junctions (thick and thin white arrows, respectively), established and
forming desmosomes (white circles), brush border (black arrowheads)
and glycogen vacuoles (asterisks).
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Figure 4 | Gene delivery into renal cells on FMB. One or two million
renal or endothelial cells were loaded and grown on FMB in rotation.
(a and b) Human embyonic renal tubular cells (HEK 293), (c and d)
low-passage murine mesangial cells and (e and f) bovine aortic cells
(BAEC). Next, cells were either infected with an Ad vector encoding
LacZ (AdCMVLacZ) at 1.25 106 infectious units for 2 h (b, d and f) or
incubated with infection media alone (a, c and e). Next, cells on FMB,
either infected with AdCMVLacZ (right panel) or not (left) was stained
with X-gal 2 days after infection. Arrow in right panel of (b) indicates
empty FMB, in contrast to FMB loaded with dark blue mesangial cells
signifying robust LacZ gene delivery.
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replication-competent AdE1LacZ could efficiently kill the
renal cancer cells in monolayer within 6–7 days, its oncolytic
effect was attenuated in the 3D model (Figure 7c, d and f). Of
note, AdE1LacZ could kill cells on FMB as of the first day
after infection (Figure 7d) because the MOI of AdE1LacZ
(identical MOI to Adempty) was higher than that used for
AdD24RGDGFP and AdRGD-GL in the previous experiment.
However, in sharp contrast to CaKi-1 cells in monolayer,
the oncolytic effect of the replicative virus (AdE1LacZ) was
again attenuated in the FMB model, as evident by a less steep
killing rate curve (Figure 7f). Thus, this assay confirmed that
CaKi-1 cells growing on FMB were more resistant to
oncolytic Ad than those in monolayer culture. We estimate
that the oncolytic resistance factor for cells on FMB vs
monolayer is between threefold (Figure 7e) and sixfold
(Figure 7f). Of note, whereas Adempty had no cell killing
effect in the monolayer model, it resulted in moderate degree
of cell killing in the FMB model (see Discussion). Taken
together, these results indicate that the kinetics of cell survival
on FMB, gene expression and cell killing by replicating Ad
may differ significantly in human renal cancer cells grown on
FMB vs standard monolayer cell culture.
FMB can serve as a matrix for MSC growth and transduction
Recently, MSCs were shown to protect kidneys from acute
tubular necrosis, unlike hematopoietic stem cells.20,22 Pre-
viously, our group employed FMB to isolate and grow
MSC.18,29 Using the same technique, we isolated MSC from
rat, Balb/C mouse and a GFP-transgenic mouse. The
pluripotency of these MSC has been demonstrated via
differentiation into several lineages, that is, osteocytes,
chondrocytes and adipocytes, both in monolayers,19 and on
FMB (manuscript in preparation). In our experiments, MSC
grew robustly on FMB (Figure 8) and could be downloaded
onto monolayers without trypsinization, thereby establishing
novel MSC cell lines. On FMB, MSC thrived and could be
efficiently transduced via Ad, herpes simplex virus and
lentiviral vectors (Figure 8). Thus, FMB may be useful as a
cell culture matrix in the context of cell and gene therapy for
renal disorders.
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Figure 5 | Renal cancer cells in monolayer are efficiently lysed by
oncolytic Ad. Two million CaKi-1 human renal cancer cells were
grown in monolayer and infected with 4 103 infectious units of
either the non-replicative Ad vector encoding GFP, AdRGD-GL (left) or
its replication-selective equivalent Ad, AdD24RGDGFP (right). Cells
were followed daily for GFP expression and lysis. Images are
presented as merged GFP expression (captured with fluorescence
microscopy) and phase images of same fields,  10.
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Figure 6 | Renal cancer cells on FMB are more resistant to
oncolytic Ad. Two million CaKi-1 human renal cancer cells were
grown on FMB and infected with either the non-replicative Ad vector
encoding GFP, AdGL-RGD (left) or its replication-competent equiva-
lent Ad, AdD24RGDGFP (right), exactly as above in Figure 5. Cells
were followed daily for GFP expression and cell death. Note
diminished GFP expression by the non-replicative Ad and the
propagation of gene expression by the replication-competent Ad
(a and b). However, gene expression subsided after 2 weeks in cells on
FMB infected with the replicative Ad (c and d). Renal cancer cells
on FMB, infected with the replication-competent Ad were still viable
on days 5–6, unlike those in monolayer, but died after 11–14 days
(g and h), acridine orange–ethidium bromide double stain, right).
Note that figures (g) and (h) were taken under identical conditions
and are presented as merged images of two fluorescent channels,
where green color indicates viable cells and yellow-orange indicates
that cells are dead. Even after cell death, cells on FMB were not lysed
completely and remained adherent to the FMB matrix (e and f
Hoechst stain, right).
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DISCUSSION
Cell and gene therapy may potentially alter the natural course
of both acquired and hereditary renal diseases, such as Alport
syndrome, glomerulonephritis, allograft nephropathy and
renal cancer. While many aspects of kidney cell and gene
therapy are critically limited in vivo, 3D in vitro systems may
provide valuable information superior to that of standard
monolayer cell cultures in general,10–12, 23–25 and in the
context of cell–vector interaction in particular.13,15 In this
regard, a number of genes may be specifically upregulated or
downregulated in 3D culture systems vs monolayers,
inclusive of viral receptors,14 thereby directly affecting cell
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Figure 7 | Quantitative assessment of renal cell oncolysis in monolayer vs FMB. CaKi-1 renal cancer cells were grown in monolayer and on
FMB and infected as described below. (a and b) Indirect assessment of cell killing with LDH levels in monolayer (a) or FMB (b) after infection
with the non-replicative Ad vector encoding GFP AdRGD-GL (black bars) or its replication-competent equivalent Ad, AdD24RGDGFP (striped
bars), applied each at an MOI of 1:500. Media were collected daily and assayed for LDH activity, as an index of cell killing. LDH levels are
presented as the percentage of baseline LDH levels from media collected from CaKi-1 cells infected with the non-replicative AdRGD-GL. (c and
d) MTS assay to measure quantitatively renal cancer cell viability. After calibration and derivation of standard curve between cell number and
OD readings, CaKi-1 cells were grown in monolayer (c) or on FMB (d). The background OD reading for FMB unloaded with cells corresponded
to a cell number of 0.35 103 and was not subtracted from the cell number measurement. Following infection with the non-replicative Ad
vector AdEmpty (blank bars), or its replication-competent equivalent Ad, AdE1LacZ (striped bars), both applied at an MOI of 1:15, cell viability
was assessed over time using the MTS assay. Numbers of viable cells were derived from previous standard curve calibration of OD readings
correlating with increasing numbers of seeded cells. Black bars indicate mock infection without virus, reflecting spontaneous cell growth.
(e and f) Oncolysis in the FMB model is attenuated vs monolayer culture, presented as cell killing efficiency (e, evaluated by the percentage of
LDH levels in media of cells infected with the replicative Ad relative to baseline levels in media of AdRGD-GL-infected cells on day 1, data
derived from (a anf b) or as cell viability (f, evaluated by the percentage of viable cells infected with the replicative Ad relative to same-day cell
number in the no-virus control, data derived from (c and d)). *Po0.05 for significant viral oncolysis, **Po0.01 for significant viral oncolysis,
m¼ slope of curve.
Table 1 | Viral vectors used in the study
Vector
1 2 3 4 5 6 7
AdCMVLacZ HSV-LacZ Lenti-GFP AdRGD-GL Adempty AdD24RGDGFP AdE1LacZ
Replication competent No No No No No Yes Yes
Transgene LacZ LacZ GFP GFP and luciferase No GFP LacZ
Capsid modification No No No RGD No RGD No
Used in figure Figures 4 and 8 Figure 8 Figure 8 Figures 5–7 Figure 7 Figures 5–7 Figure 7
Ad=adenovirus; GFP=green fluorescent protein; GL=GFP+luciferase; HSV=herpes simplex virus; RGD=arginine, glycine, aspartate.
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survival and gene delivery.13,15,24 Thus, 3D culture systems
may be superior to standard cell culture to study some
aspects of renal cell biology.
In this study, we employed FMB as a 3D matrix to grow
and transduce renal cells. This system allowed the study of
renal cell growth, differentiation and transduction in 3D.
A variety of renal cells could be grown and transduced in 3D
on FMB. Cellular growth on FMB had an impact on cell
survival as evident in (i) robust, multilayered cellular growth
of renal cell lines and (ii) relative resistance to cell killing and
lysis by oncolytic viruses. These findings probably mimic in
vivo conditions more closely than 2D cell culture and
underscore the significance of relevant in vitro models.
In the context of viral-mediated oncolysis, a rapidly
growing field where replication-selective viruses are em-
ployed to kill cancer cells via tumor-specific replication,25,27 a
major constraint on tumor-targeted oncolytic viruses is their
limited spread in solid tumors,28,29 resulting among others
from physical factors such as basement membranes, necrotic
regions and extracellular matrix.30 Our system may thus
provide a novel 3D matrix to evaluate the antitumor effect of
oncolytic viruses. FMBs are comprised of both cancer cells
and stroma, thereby setting an intermediate model between
monolayers and tumors. As the stroma may confer survival
signals for tumor cells and allows multilayered cell growth, it
is not surprising that lysis of renal cancer cells on FMB lagged
behind cell killing in monolayers. Another mechanism that
may account for the relative resistance to oncolysis of renal
cancer cells growing on FMB is variability in cell cycle. Unlike
monolayer cancer cell culture where all cells are cycling, cells
growing in 3D such as in tumors or spheroids are frequently
in G0 phase.31 As cells in S phase are more susceptible to cell
killing by oncolyic Ad,31,32 cells growing in monolayer may
thus be killed more efficiently. Of note, the non-replicative
Adempty also attenuated to some degree cell growth on FMB
(Figure 7d), but not in monolayer (Figure 7c). Possibly, E1
gene may be transcomplemented by the cancer cells growing
on FMB, as previously suggested in monolayers.33 However,
perhaps more likely is a low-degree of wild-type Ad contami-
nation that was propagated only in cells on FMB infected
with Adempty where the absolute viral particle number
applied was higher, to comply with the same MOI applied for
the cells in monolayer.
Our model also provides insight into the pattern of
amplification of gene expression by replicative viruses.
Whereas the replication-incompetent AdRGD-GL hardly
yielded any GFP expression under the low MOI conditions,
both in monolayer and in cells on FMB, the replication-
competent AdD24RGDGFP induced substantial gene expres-
sion under the same MOI. Furthermore, in cells grown as
monolayer, GFP expression increased dramatically and
simultaneously in a few days and was a marker of imminent
cell lysis by the replicative Ad. In contrast, the pattern of GFP
expression in renal cancer cells on FMB matrix infected by
AdD24RGDGFP was migratory and gradual. The cells in 3D
were probably serially infected by the virus, expressed GFP,
lysed and released more virus into the medium to begin a
new cycle. However, the process of cell killing on FMB was
attenuated and much less efficient than that under monolayer
conditions. Thus, our FMB model may mimic in vivo
conditions where viral vector-mediated gene delivery and
viral and DNA replication are unsynchronized, unlike
monolayer conditions.
Another important finding of this study was viral vector-
mediated gene delivery into MSC cells on FMB. As MSC are
potential candidates for kidney cell therapy and because MSC
thrive on FMB, in the range of 107–108/ml of packed
FMB,17,18 ex vivo transgene delivery into MSC is of
considerable interest. In this regard, heterologous gene
delivery may be either episomal and transient (e.g. via Ad
vectors) or integrative into the cellular genome (e.g. via
lentiviral or retroviral vectors). The FMB model allowed
efficient gene delivery via both types of viral vectors into
MSC grown on FMB in large numbers. This strategy may
mMSC+
Ad-LacZ
mMSC+
HSV-LacZ
rMSCs+
Lenti-GFP
mGFP-MSC
Reporter gene (+)Reporter gene (–)
a
dc
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f
g h
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Figure 8 | FMB as a matrix for MSC growth and transduction. Bone
marrow was flushed out from femurs and tibias of various rodents
(rats, mice, transgenic GFP mice). Cells (1.5 107) were loaded onto
FMB and grown in rotation for 48 h. Cell growth was monitored via
fluorescence microscopy for GFP MSC and via PI stain for other MSC.
Pluripotency of each MSC was demonstrated as in Gurevich et al.25
(data not shown). (a and b) MSCs from transgenic GFP mice. Left,
phase microscopy image. Right, fluorescence microscopy image.
(c and f), Mouse MSC were either incubated with infection media
alone (c and e) or infected with a viral vector encoding LacZ (d and f),
and stained with X-gal. Viral vectors were either AdCMVLacZ (d) or
HSV-LacZ (f). (g and h) MSC from rat were either incubated with
infection media alone (g, stained with PI) or infected with lentivirus
encoding GFP (h).
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eventually prove highly efficient to transduce MSC before in
vivo delivery.
In conclusion, 3D renal cell growth on FMB appears
distinct from standard monolayer renal cell culture, as
manifested by robust and prolonged cellular expansion and
relative resistance to oncolytic viruses. Furthermore, FMB
can be used to grow and transduce MSC that may be
potentially beneficial for kidney recovery from both acute
and chronic insults. Thus, on the basis of controlled
microenvironment for cell growth, FMB may emerge as a
meaningful 3D matrix for cell and gene therapy endeavors in
the context of renal disorders.
MATERIALS AND METHODS
FMB preparation
FMB were fabricated at HAPTO Biotech Ltd (Jerusalem, Israel)
from human fibrinogen and thrombin by an oil emulsion
procedure, as reported previously.17–19 Briefly, fibrinogen was
isolated from 1 l pooled, screened human plasma (Shaare Zedek
Blood Bank, Jerusalem, Israel) by cold 8% ethanol precipitation and
centrifuged. The supernatant was decanted and the precipitated
fibrinogen was dissolved by warming to 371C. Medium chain tri-
gly-ceride oil (B2 l; Adumim Food Additives, Maale Adumim,
Israel) was heated to 751C and stirred at 250 r.p.m. The formulated
fibrinogen solution was mixed with thrombin (5 U/ml) and the
mixture added to the stirred, heated oil. The resultant droplets
became coagulated, heat denatured and cross-linked by endogenous
factor XIII. After more than 5 h heating, all the water had
evaporated out of the droplets, leaving small particulates of fibrin.
These were isolated by decanting the oil, and then washed with
hexane, ethanol and acetone. The dried crude FMB (2.5 g) were
passed through a series of sieves (Cole Parmer International,
Vernon-Hilly, IL) to yield spheroidal particles with diameters in the
range 75–106, 108–180 and 180–250mm. The density of the FMB,
determined by centrifugation in a sucrose gradient, wasB1.25 g/ml.
Cell lines
HEK 293 (human embryonic renal tubular cells stably expressing the
Ad E1 gene), rhesus monkey tubular epithelial (Vero), canine renal
tubular epithelial (Madin–Carby canine kidney), porcine epithelial
kidney (LLC-PK1) and bovine aortic endothelial cell lines were
originally from American Type Culture Collection and grown in
Dulbecco’s minimum essential medium, 10% fetal calf serum (FCS),
1% antibiotics (penicillin–streptomycin) and 1% glutamine. Cancer
kidney cells (CaKi-1) were grown in McCoy’s 5-A medium with 10%
FCS, 1% antibiotics and 1% glutamine. Rat MSC, LZ100, a
multipotent bone-marrow derived cell line, was grown in minimal
essential medium (MEM) a medium supplemented with 10% FCS,
1% antibiotics, 1% glutamine, MEM vitamin solution 1 and 1%
MEM–non-essential amino-acid solution. Podocytes (from P
Mundel, Albert Einstein College of Medicine, New York, NY), a
conditionally immortalized human podocyte cell line with the
temperature-sensitive SV40-T antigen, were grown as in Saleem
et al.,34 and were loaded onto rotating FMB at the permissive
temperature (331C). Primary murine mesangial cells were isolated
following procedure described in Mene et al. and Elger et al.35,36 and
provided by C Putterman (Albert Einstein College of Medicine). All
culture media, FCS and supplements were purchased from
Biological Industries (Beit-HaEmek, Israel).
Primary kidney cells
A rat kidney was dissected into four major compartments, that is,
cortex, papilla, inner medulla and outer medulla. The tissues were
minced into 5 mm slices and incubated with 1 mg/ml collagenase
type II (Worthington Biochemical Corporation) and Dulbecco’s
minimum essential medium containing 1% antibiotics, 1%
glutamine, with no FCS, at 371C in a humid incubator. After 2 h,
the tissues were homogenized by manual pipetting. The liquid tissue
was loaded onto FMB for 2 weeks, non-adherent cell rinsed and cells
on FMB further grown and monitored as described below.
Isolation of MSC from transgenic GFP murine bone marrow
Bone marrow from GFP-transgenic mouse (C57BL/6-Tg(ACTB-
EGFP)1Osb/J, Jackson) was flushed out from the femur and tibia
and propagated via needles with serially reduced diameters to obtain
a monocellular suspension. Next, cells were suspended in 10 ml of
Dulbecco’s minimum essential medium with 20% FCS, 1% anti-
biotics, 1% glutamine, MEM vitamin solution 1 and 1% MEM–non-
essential amino-acid solution, and loaded onto 150ml of packed FMB
in a 50-ml polycarbonate tube as described below.
Loading cells on FMB
Two to five million renal cells were suspended in 10 ml of the
matching medium with 150ml of packed FMB in a 50-ml
polycarbonate tube. The tubes were closed with perforated caps
and covered by aluminum foil, to allow gas exchange while avoiding
contamination. The tubes were placed in a 371C, water-jacketed, 6%
CO2 incubator on a slowly rotating stand (B10 cycles/min) at an
angle of 301, to avoid medium spillage. One week later, non-
adherent cells were shaken off by gentle mix, and the FMB with
attached cells were allowed to sediment for 60–90 s. The supernatant
was then removed, medium replaced and the tubes with cells on
FMB returned onto the rotator. Periodically, samples were examined
to evaluate cellular expansion on FMB.
Assessment of cell growth and viability on FMB
For routine evaluation of cell growth on FMB, aliquot samples were
fixed with 70% ethanol for 10 min and stained with propidium
iodide (PI; 5 mg/ml) for 5–10 min in the dark. Alternatively, cells on
FMB were stained with Hoechst 33252 (Sigma), at 1 ml/ml for 2 min
following fixation with 3.7% formaldehyde/phosphate-buffered
saline. The PI- or Hoechst-stained cells were then mounted on a
microscope slide with mounting medium (Sigma) and visualized via
fluorescence microscopy.
The red (PI) or blue (Hoechst) staining was specific to nuclei and
only minimally stained the FMB. Alternatively, live cells were also
double stained with acridine orange–ethidium bromide to assess cell
viability (green) or death (orange). For experiments studying renal
cancer cell resistance to infection with oncolytic viruses, we
employed two assays to evaluate cell viability. First, MTS assay
was used to evaluate the number of live cells via assessment of
mitochondrial metabolism as measured by optic density (OD)
reading in a plate reader. Initial calibration of OD readings with the
number of seeded cells allowed the quantitative measurement of
growing cells in monolayers and on FMB. Second, media were
collected daily for LDH isoenzyme levels, a marker of cell death.
TEM of cells on FMB
LLC-PK1 renal epithelial cells growing on FMB were fixed in 2.5%
gluteraldehyde, embedded in Eprom and thin sections prepared
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therefrom. After staining with uranylacetate, the samples were
examined via TEM at various magnifications (up to 20 000).
Viral vectors and gene delivery in 3D cell culture
The viral vectors used in the various experiments are shown in
Table 1. Replication-incompetent vectors are identified as nos. 1–5,
and replication-competent viruses are nos. 6 and 7. For the cell
killing assays, we employed two pairs of Ad vectors, each comprising
a replication-competent and replication-incompetent Ad. The first
pair of Ad vectors comprised the replication-incompetent Ad vector
AdRGD-GL (encoding GFP and RGD capsid-modified) and its
replication-competent equivalent, AdD24RGDGFP (vector nos. 4
and 6, respectively, Table 1)).
AdD24RGDGFP is the conditionally replicative version of
AdRGD-GL, as it is GFP-encoding, RGD-capsid-modified, replica-
tion-selective Ad where a 24-bp deletion in the E1A gene selects for
replication in cancer cells with retinoblastoma-defective pathway.
AdGL-RGD and AdD24RGDGFP were provided by Drs H Wu and
D Curiel, Division of Human Gene Therapy (University of
Birmingham, AL).37,38 The second pair comprised the replication-
incompetent Adempty vector (no. 5, Table 1), whereas its
replication-competent equivalent was AdE1LacZ (replication-com-
petent Ad virus encoding the E1 gene required for viral replication
and also encoding LacZ (no. 7, Table 1)). All Ad vectors were titered
for determination of infectious units on 293 cells, whereas the
lentiviral and herpes simplex virus vectors were titered for infectious
units on Vero cells. To evaluate gene delivery in 3D into cells on
FMB, HEK 293, mesangial cells or endothelial cells (BAEC) were
loaded onto FMB in a rotating suspension. After attachment,
1.25 106 infectious units of the respective viral vector were
incubated within the rotating suspension for 2 h, followed by
thorough rinsing and replacement with fresh medium. Gene
delivery was evaluated 48 h later with X-gal staining. Briefly, cells
on FMB were rinsed with phosphate-buffered saline, fixed via
fixative solution (glutaraldehyde 0.2%, formalaldehyde 2%, MgCl2
2 mM and phosphate-buffered saline) applied on FMB cells for
20 min, rinsed again and stained with 1:40 (v/v) X-gal in dimethyl
sulfoxide 20 mg/ml, potassium ferrocyanide 0.5 mM, potassium
ferricyanide 0.5 mM, MgCl2 2 mM and phosphate-buffered saline in
the dark at 371C. Lentiviral gene delivery was evaluated after lenti-
GFP incubation as above with rat MSC (LZ100) on FMB and
fluorescence imaging 24 h later.
3D viral-mediated cytolysis (oncolysis) in renal cancer cells
CaKi-1 (human renal cancer cell line) cells were grown either in
monolayer or in rotation on FMB in 50 ml tubes. As all other
conditions were identical, quantitative assessment of renal cancer
cell viability could serve to differ between cell growth and survival in
the two different culture conditions. To evaluate viral-mediated
cancer cell killing (oncolysis), we employed two pairs of replication-
competent Ad viruses vs replication-incompetent Ad vectors, as
described above. The replicative AdD24RGDGFP or its replication-
incompetent control AdRGD-GL (vector nos. 6 and 4, respectively,
Table 1) were applied at an MOI of 1:500 (i.e., 4 103 infectious
units to infect 2 106 CaKi-1 cells seeded in monolayer or on FMB).
As both AdD24RGDGFP and AdRGD-GL encode GFP, assessment of
GFP with fluorescence microscopy could indicate the propagation of
infection. Cell killing was measured indirectly via LDH levels in the
media and qualitatively by direct staining of CaKi-1 cells on FMB
with acridine orange–ethidium bromide double stain or Hoechst
nuclear stain. In the second experiment, oncolysis was evaluated
quantitatively by the MTS assay. In this experiment, increasing
numbers of CaKi-1 cells were serially seeded both in monolayer and
on FMB. To determine quantitatively the respective cell number, we
employed standard curve calibration of OD reading vs cell number.
Next, either the replicative AdE1LacZ or its replication-incompetent
control Ad empty (vector nos. 7 and 5, respectively, Table 1) were
applied each to infect CaKi-1 cells in monolayer or on FMB at an MOI
of 1:15 (i.e., 1 104 infectious units to infect 1.5 105 cells on FMB
and 1 102 infectious units to infect 1.5 103 cells in monolayer).
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